In breast cancer, NONO promotes cancer cell proliferation by regulating the pre-mRNA splicing of genes related to cell proliferation, such as S-phase kinase-associated protein 2 and E2F transcription factor 8, and the expression level of NONO is significantly correlated with the prognosis of breast cancer patients [31]. This evidence concerns the gene E2F8 and breast carcinoma.